Evolution of tricuspid endocarditis without surgical condition
DOI:
https://doi.org/10.5281/zenodo.13371228Keywords:
Infectious Endocarditis, Tricuspid Valve, HIVAbstract
Infectious Endocarditis (IE) is a disease with high morbidity and mortality, being more common on the left side of the heart. Right-sided IE (DIE) is relatively rare, involving 5-10% of cases. The tricuspid valve is the most affected, while the pulmonary valve is involved in 10% of cases. EID is strongly associated with the use of intravenous drugs, as well as devices such as pacemakers, defibrillators, catheters and vascular access. Right-sided infective endocarditis presents surgical indications based on widely established criteria, which may be associated with important predictors that increase the mortality rate. In this context, isolated clinical therapy can be essential for managing the case and its outcome.
References
CICALINIA, S, et al. Infective Endocarditis in Patients with Human Immunodeficiency Virus Infection. Journal of infection, Department of Infectious and Tropical Diseases, University "La Sapienza" of Rome, p. Pages 267-271, 4 jul. 2001.
SEXTON, Daniel J; CHU, Vivian H. Infective Endocarditis in People who Inject Drugs.
HUSSAIN, Syed T, et al. Tricuspid valve endocarditis. Annals of Cardiothoracic Surgery.
SPELMAN, Denis, et al. Complications and outcome of infective endocarditis.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Social Issues and Health Sciences (JSIHS)

This work is licensed under a Creative Commons Attribution 4.0 International License.
